XML 37 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
9 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of weighted average assumptions
We utilized the Black-Scholes option valuation model with the following weighted average assumptions:
 
 
Nine Months Ended
March 31,
 
2020
 
2019
Risk-free interest rate
1.5
%
 
2.8
%
Expected dividend yield
0.0
%
 
0.0
%
Expected life (in years)
4.5

 
4.6

Expected volatility factor
26.8
%
 
26.6
%

Schedule of stock-based compensation expense
The stock-based compensation expense under all equity plans and its classification in the unaudited consolidated statements of operations for the three and nine months ended March 31, 2020 and 2019 are as follows:
 
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2020
 
2019
 
2020
 
2019
 
(Dollars in Thousands)
Recorded as expenses:
 

 
 

 
 

 
 

Cost of maintenance
$
343

 
$
379

 
$
1,104

 
$
916

Cost of services and other
450

 
366

 
1,477

 
1,038

Selling and marketing
1,472

 
1,228

 
4,228

 
3,687

Research and development
2,082

 
1,518

 
6,193

 
5,451

General and administrative
2,952

 
2,763

 
11,131

 
10,362

Total stock-based compensation
$
7,299

 
$
6,254

 
$
24,133

 
$
21,454



Schedule of stock option and RSU activity
A summary of stock option and restricted stock unit ("RSU") activity under all equity plans for the nine months ended March 31, 2020 is as follows:
 
 
Stock Options
 
Restricted Stock Units
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic Value
(in 000’s)
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Outstanding at June 30, 2019
1,304,017

 
$
60.33

 
6.94
 
$
83,388

 
793,718

 
$
98.38

Granted
297,504

 
133.05

 
 
 
 

 
266,237

 
133.39

Settled (RSUs)

 
 

 
 
 
 

 
(204,114
)
 
85.16

Exercised
(84,571
)
 
53.06

 
 
 
 

 

 
 

Cancelled / Forfeited
(30,851
)
 
99.18

 
 
 
 

 
(83,951
)
 
112.68

Outstanding at March 31, 2020
1,486,099

 
$
74.50

 
6.80
 
$
46,116

 
771,890

 
$
112.39

Vested and exercisable at March 31, 2020
980,407

 
$
56.76

 
5.87
 
$
41,571

 

 
 

Vested and expected to vest as of March 31, 2020
1,429,077

 
$
73.10

 
6.73
 
$
45,612

 
726,960

 
$
112.46